Document Detail

The role of the TGF-β family in wound healing, burns and scarring: a review.
MedLine Citation:
PMID:  22928164     Owner:  NLM     Status:  PubMed-not-MEDLINE    
It is estimated worldwide that over 6 million people per annum experience a burn injury. Despite advances in management and improved survival rates, the incidence of hypertrophic scarring remains high. These scars are particularly common after burns and are often raised, red, hard and may cause abnormal sensations. Such pathological scarring can lead to severe functional impairment, psychological morbidity, and costly long term healthcare. Wound healing is an inherent process which restores the integrity of the skin after injury and although scarring is a frequent by-product, the scarless wound healing observed in early human gestational fetuses suggests that it is not an essential component of the response. This has lead to a large body of research attempting to understand the mechanisms behind scarring and in turn prevent it. One of the main focuses of recent research has been the role played by the growth factor TGF-β in the process of both wound healing and scar formation. The three isoforms (TGF-β1, TGF-β2 and TGF-β3) appear to have overlapping functions and predominantly mediate their effects through the intracellular SMAD pathway. Initial research suggested that TGF-β1 was responsible for the fibrotic scarring response whereas the scarless wound healing seen in fetal wounds was due to increased levels of TGF-β3. However, the reality appears to be far more complex and it is unlikely that simply altering the ratio of TGF-β isoforms will lead to scarless wound healing. Other aspects of the TGF-β system that appear promising include the downstream mediator CTGF, the proteoglycan decorin and the binding protein p311. Other putative mechanisms which may underlie the pathogenesis of hypertrophic scars include excessive inflammation, excessive angiogenesis, altered levels of matrix metalloproteinases, growth factors, and delayed apoptosis of fibrotic myofibroblasts either due to p53 genetic alterations or tensile forces across the wound. If an effective treatment for hypertrophic scars following burns injury is to be developed then further work must be carried out to understand the basic mechanisms of pathological scarring.
Jack W Penn; Adriaan O Grobbelaar; Kerstin J Rolfe
Related Documents :
2191424 - Immune events associated with inflammatory bowel disease.
19735074 - Targeted therapy to the il-2r using diphtheria toxin and caspase-3 fusion proteins modu...
18656634 - Transanal delivery of angiotensin converting enzyme inhibitor prevents colonic fibrosis...
19072354 - Expression of toll-like receptors in the intestinal mucosa of patients with inflammator...
24922524 - Effect of tacrine-3-caffeic acid, a novel multifunctional anti-alzheimer's dimer, again...
15245744 - Pathogens use carbohydrates to escape immunity induced by dendritic cells.
Publication Detail:
Type:  Journal Article     Date:  2012-02-05
Journal Detail:
Title:  International journal of burns and trauma     Volume:  2     ISSN:  2160-2026     ISO Abbreviation:  Int J Burns Trauma     Publication Date:  2012  
Date Detail:
Created Date:  2012-08-28     Completed Date:  2012-08-30     Revised Date:  2013-05-30    
Medline Journal Info:
Nlm Unique ID:  101581623     Medline TA:  Int J Burns Trauma     Country:  United States    
Other Details:
Languages:  eng     Pagination:  18-28     Citation Subset:  -    
The Institute of Plastic Surgery, Research and Education. Dept Plastic Surgery, The Royal Free Hospital Pond St Hampstead, London UK, NW3 2QG.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The Th-17 response and its potential role in post-injury pulmonary complications.
Next Document:  Nanomaterials and nanotechnology for skin tissue engineering.